DGAP-News

Fresenius Medical Care AG & Co. KGaA: Closes Acquisition of Liberty Dialysis Holdings (deutsch)

Fresenius Medical Care AG & Co. KGaA: Closes Acquisition of Liberty Dialysis Holdings

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s):

Acquisition

Fresenius Medical Care AG & Co. KGaA: Closes Acquisition of Liberty

Dialysis Holdings

29.02.2012 / 07:40

---------------------------------------------------------------------

Contact: Fresenius Medical Care AG & Co. KGaA

Oliver Maier Else-Kröner-Str.1

Phone: + 49 6172 609 2601 61352 Bad Homburg

Fax: + 49 6172 609 2301 Germany

www.fmc-ag.com

North America:

Terry L. Morris

Phone: + 1 800 948 2538

Fax: + 1 615 345 5605

E-mail: [e-mail] February 29, 2012

Investor News

Fresenius Medical Care Closes Acquisition of Liberty Dialysis Holdings

Bad Homburg, Germany - Fresenius Medical Care AG & Co. KGaA (the 'company'

or 'Fresenius Medical Care'; Frankfurt Stock Exchange: FME / New York Stock

Exchange: FMS), the world's largest provider of dialysis products and

services, today announced that Fresenius Medical Care North America has

closed the acquisition of Liberty Dialysis Holdings, Inc., the holding

company of Liberty Dialysis and Renal Advantage. The closing follows the

completion of the review of the transaction and issuance of a consent

decree by the United States' Federal Trade Commission. In connection with

the consent decree, Fresenius Medical Care intends to divest 62 dialysis

clinics. The acquisition of Liberty Dialysis Holdings Inc. is expected to

add annual revenues of around $ 700 million and 201 clinics to Fresenius

Medical Care's network for an investment, net of proceeds from the

divestiture, of approximately $1.5 billion.

Rice Powell, chief executive officer of Fresenius Medical Care North

America and deputy chairman of Fresenius Medical Care commented, 'We're

excited to add the teams from Liberty Dialysis and Renal Advantage to our

network. Both companies have shown superior growth and solid clinical

outcomes, which are testaments to the strength of their management teams

and the dedication of their physician leadership. The combination of these

businesses with the resources and committed team at Fresenius Medical Care

will further enhance our standing as North America's premier renal care

network.'

About Fresenius Medical Care

Fresenius Medical Care is the world's largest integrated provider of

products and services for individuals undergoing dialysis because of

chronic kidney failure, a condition that affects more than 2 million

individuals worldwide. Through its network of 2,898 dialysis clinics in

North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius

Medical Care provides dialysis treatment to 233,156 patients around the

globe. Fresenius Medical Care is also the world's leading provider of

dialysis products such as hemodialysis machines, dialyzers and related

disposable products.

Disclaimer

This release contains forward-looking statements that are subject to

various risks and uncertainties. Actual results could differ materially

from those described in these forward-looking statements due to certain

factors, including changes in business, economic and competitive

conditions, regulatory reforms, foreign exchange rate fluctuations,

uncertainties in litigation or investigative proceedings, and the

availability of financing. These and other risks and uncertainties are

detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the

U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co.

KGaA does not undertake any responsibility to update the forward-looking

statements in this release.

End of Corporate News

---------------------------------------------------------------------

29.02.2012 Dissemination of a Corporate News, transmitted by DGAP - a

company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------

Language: English

Company: Fresenius Medical Care AG & Co. KGaA

Else-Kröner-Straße 1

61352 Bad Homburg

Germany

Phone: [phone]

Fax: [phone]

E-mail: [e-mail]

Internet: www.fmc-ag.de

ISIN: DE0005785802, DE0005785836,

WKN: 578580, 578583

Listed: Regulierter Markt in Frankfurt (Prime Standard);

Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,

München, Stuttgart; Terminbörse EUREX; NYSE

End of News DGAP News-Service

---------------------------------------------------------------------

158572 29.02.2012